Home›Companies›Biotech & Pharma›Pharmazz

Pharmazz, Inc.

Develops and sells medicines for patients with critical care conditions.

Updated Nov 10, 2026·Latest SEC filing Jul 28, 2026·Suggest an edit

About Pharmazz

Pharmazz is a private company based in Willowbrook, Illinois. It has reported $31,957,603 raised in ten offerings on Form D since February 2018. Its chief executive is Anil Gulati.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 13, 2026Jul 28, 2026$250,000of $3.5M target1$250KEquityRule 506(b)Form D ↗
May 27, 2025Jun 11, 2025$10,037,500of $25.0M target1$10.0MEquity, OptionsRule 506(b)Form D ↗
Aug 15, 2024Aug 30, 2024$7,500,000of $15.0M target1$7.5MOptions, Securities on exerciseRule 506(b)Form D ↗
Feb 2, 2024Feb 16, 2024$150,000of $6.0M target2$75,000Options, Offering of Simple Agreement for Future Equity (SAFE) with WarrantRule 506(b)Form D ↗
Oct 24, 2023Nov 2, 2023$450,000of $15.0M target3$150KOffering of Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗
Oct 18, 2022May 18, 2023$2,300,000of $6.5M target16$143KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Apr 12, 2021Apr 29, 2021amended May 18, 2023$5,450,000fully sold28$194KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Feb 14, 2020Mar 3, 2020$1,405,500of $5.0M target1$1.4MEquityRule 506(b)Form D ↗
Jul 31, 2018Aug 7, 2019amended Nov 14, 2019$3,691,000fully sold23$160KEquityRule 506(b)Form D/A ↗1 earlier filing
Jan 18, 2018Feb 1, 2018amended Aug 6, 2019$723,603fully sold16$45,225EquityRule 506(b)Form D/A ↗1 earlier filing
Total, ten offerings$31,957,603

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pharmazz's Form D filed Jul 28, 2026.

DM
Dharminder Marwah
Executive officer and director
JM
Jane Kiernan
Jane Kiernan
Director
Atul Raut
Atul Raut
Director
Sunil Gulati
Sunil Gulati
Chief Operating Officer
Anil Gulati
Anil Gulati
Chairman and Chief Executive Officer
David Costello
David Costello
Vice President, Corporate Affairs

Earlier filings also listed James McConnell (director, last listed Aug 2024), Daniel Stauder (executive officer, last listed Aug 2024), Gaylord Toft (executive vice president, last listed Mar 2020) and Ajit Srimal (director, last listed Mar 2020).

Sources

  1. SECPharmazz, Inc. Form D, filed Apr 29, 2021
  2. SECPharmazz, Inc. Form D, filed Aug 7, 2019
  3. SECPharmazz, Inc. Form D, filed Feb 1, 2018
  4. SECPharmazz, Inc. filing history
  5. CompanyContact
  6. CompanyAbout Pharmazz
  7. CompanyManagement
  8. CompanyDirectors and advisors